UB Paderborn / Katalog / Suche / in CDI

Es ist ein Fehler in der Kommunikation mit einem externen System aufgetreten. Bitte versuchen Sie Ihre letzte Aktion erneut. Sollte der Fehler bestehen bleiben, setzen Sie sich bitte mit dem Informationszentrum der Bibliothek in Verbindung oder versuchen Sie es später erneut.

1 – 25 von 162

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Use of doping agents, particularly anabolic steroids, in sports and society

The Lancet (British edition), 2008, Vol.371 (9627), p.1872-1882

2008

Volltextzugriff (PDF)

Development of Clinical Pharmacology as a Medical Speciality in Europe – The Roles of WHO, IUPHAR and EACPT

Basic & clinical pharmacology & toxicology, 2014-08, Vol.115 (2), p.172-178

Sjoqvist, Folke

2014

Volltextzugriff (PDF)

Pharmacokinetics of losartan and its metabolite E‐3174 in relation to the CYP2C9 genotype

Clinical pharmacology and therapeutics, 2002-01, Vol.71 (1), p.89-98

2002

Volltextzugriff (PDF)

Validation of Methods for CYP2C9 Genotyping: Frequencies of Mutant Alleles in a Swedish Population

Biochemical and biophysical research communications, 1999-01, Vol.254 (3), p.628-631

1999

Volltextzugriff (PDF)

Clinical pharmacology in Stockholm 50 years—report from the jubilee symposium

European journal of clinical pharmacology, 2018-06, Vol.74 (6), p.843-851

2018

Volltextzugriff (PDF)

Clinical Pharmacology in European health care—outcome of a questionnaire study in 31 countries

European journal of clinical pharmacology, 2013-09, Vol.69 (9), p.1635-1639

2013

Volltextzugriff (PDF)

The ‘Wise List’– A Comprehensive Concept to Select, Communicate and Achieve Adherence to Recommendations of Essential Drugs in Ambulatory Care in Stockholm

Basic & clinical pharmacology & toxicology, 2011-04, Vol.108 (4), p.224-233

2011

Volltextzugriff (PDF)

Quick onset of severe abdominal pain after codeine in an ultrarapid metabolizer of debrisoquine

Therapeutic drug monitoring, 1997-10, Vol.19 (5), p.543-544

1997

Volltextzugriff (PDF)

Pharmacogenetic methods as a complement to therapeutic monitoring of antidepressants and neuroleptics

Therapeutic drug monitoring, 2000-02, Vol.22 (1), p.114-117

2000

Volltextzugriff (PDF)

Pharmacokinetics of nortriptyline and its 10‐hydroxy metabolite in Chinese subjects of different CYP2D6 genotypes

Clinical pharmacology and therapeutics, 1998-10, Vol.64 (4), p.384-390

1998

Volltextzugriff (PDF)

Analysis of the CYP2D6 gene in relation to debrisoquin and desipramine hydroxylation in a Swedish population

Clinical pharmacology and therapeutics, 1992-01, Vol.51 (1), p.12-17

1992

Volltextzugriff (PDF)

Clinical pharmacology in research, teaching and health care: Considerations by IUPHAR, the International Union of Basic and Clinical Pharmacology

Basic & clinical pharmacology & toxicology, 2010-07, Vol.107 (1), p.531-559

2010

Volltextzugriff (PDF)

The role of CYP2C9 genotype in the metabolism of diclofenac in vivo and in vitro

European journal of clinical pharmacology, 2001-12, Vol.57 (10), p.729-735

2001

Volltextzugriff (PDF)

Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers

The Journal of pharmacology and experimental therapeutics, 2001-10, Vol.299 (1), p.164

2001

Volltextzugriff (PDF)

Inherited Amplification of an Active Gene in the Cytochrome P450 CYP2D Locus as a Cause of Ultrarapid Metabolism of Debrisoquine

Proceedings of the National Academy of Sciences - PNAS, 1993-12, Vol.90 (24), p.11825-11829

1993

Volltextzugriff (PDF)

Clinical Pharmacology in Research, Teaching and Health Care

Basic & clinical pharmacology & toxicology, 2010-07, Vol.107 (1), p.531-559

2010

Volltextzugriff (PDF)

Clinical Pharmacology in European health care—outcome of a questionnaire study in 31 countries : The future of European Clinical Pharmacology

European journal of clinical pharmacology, 2013, Vol.69 (9), p.1635-1639

2013

Volltextzugriff (PDF)

Drug clinical trials--the example with antidepressants

Läkartidningen, 2008-06, Vol.105 (23), p.1734

Sjöqvist, Folke

2008

Volltextzugriff (PDF)

The Anti Doping Hot-Line answers questions, educate, network, research...

Läkartidningen, 2013-09, Vol.110 (39-40), p.1728-1730

2013

Volltextzugriff (PDF)

Polymorphic debrisoquin hydroxylation in 757 Swedish subjects

Clinical pharmacology and therapeutics, 1988-10, Vol.44 (4), p.431-435

1988

Volltextzugriff (PDF)

EACPT 2001 in Odense was a success: now we are heading to Istanbul

European journal of clinical pharmacology, 2003-05, Vol.59 (1), p.77-78

Sjöqvist, Folke

2003

Volltextzugriff (PDF)

Depot haloperidol treatment in outpatients with schizophrenia on monotherapy: impact of CYP2D6 polymorphism on pharmacokinetics and treatment outcome

Therapeutic drug monitoring, 2007-08, Vol.29 (4), p.417-422

2007

Volltextzugriff (PDF)

Clinical Pharmacokinetics: The First 30 Years

Clinical pharmacokinetics, 2006-01, Vol.45 (7), p.645-647

2006

Volltextzugriff (PDF)

Determination of morphine, morphine-3-glucuronide and (tentatively) morphine-6-glucuronide in plasma and urine using ion-pair high-performance liquid chromatography

Journal of chromatography, 1982-07, Vol.230 (2), p.427-432

1982

Volltextzugriff (PDF)

The anti-doping hot-line, a means to capture the abuse of doping agents in the Swedish society and a new service function in clinical pharmacology

European journal of clinical pharmacology, 2003-11, Vol.59 (8-9), p.571-577

2003

Volltextzugriff (PDF)

1 – 25 von 162

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(142)
Mit Volltextzugriff
(93)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Use of doping agents, particularly anabolic steroids, in sports and society

Development of Clinical Pharmacology as a Medical Speciality in Europe – The Roles of WHO, IUPHAR and EACPT

Pharmacokinetics of losartan and its metabolite E‐3174 in relation to the CYP2C9 genotype

Validation of Methods for CYP2C9 Genotyping: Frequencies of Mutant Alleles in a Swedish Population

Clinical pharmacology in Stockholm 50 years—report from the jubilee symposium

Clinical Pharmacology in European health care—outcome of a questionnaire study in 31 countries

The ‘Wise List’– A Comprehensive Concept to Select, Communicate and Achieve Adherence to Recommendations of Essential Drugs in Ambulatory Care in Stockholm

Quick onset of severe abdominal pain after codeine in an ultrarapid metabolizer of debrisoquine

Pharmacogenetic methods as a complement to therapeutic monitoring of antidepressants and neuroleptics

Pharmacokinetics of nortriptyline and its 10‐hydroxy metabolite in Chinese subjects of different CYP2D6 genotypes

Analysis of the CYP2D6 gene in relation to debrisoquin and desipramine hydroxylation in a Swedish population

Clinical pharmacology in research, teaching and health care: Considerations by IUPHAR, the International Union of Basic and Clinical Pharmacology

The role of CYP2C9 genotype in the metabolism of diclofenac in vivo and in vitro

Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers

Inherited Amplification of an Active Gene in the Cytochrome P450 CYP2D Locus as a Cause of Ultrarapid Metabolism of Debrisoquine

Clinical Pharmacology in Research, Teaching and Health Care

Clinical Pharmacology in European health care—outcome of a questionnaire study in 31 countries : The future of European Clinical Pharmacology

Drug clinical trials--the example with antidepressants

The Anti Doping Hot-Line answers questions, educate, network, research...

Polymorphic debrisoquin hydroxylation in 757 Swedish subjects

EACPT 2001 in Odense was a success: now we are heading to Istanbul

Depot haloperidol treatment in outpatients with schizophrenia on monotherapy: impact of CYP2D6 polymorphism on pharmacokinetics and treatment outcome

Clinical Pharmacokinetics: The First 30 Years

Determination of morphine, morphine-3-glucuronide and (tentatively) morphine-6-glucuronide in plasma and urine using ion-pair high-performance liquid chromatography

The anti-doping hot-line, a means to capture the abuse of doping agents in the Swedish society and a new service function in clinical pharmacology

Suchergebnisse filtern